Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition.

Passacantilli, Ilaria

Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition. [electronic resource] - Oncotarget Jul 2014 - 5381-91 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1949-2553

10.18632/oncotarget.2111 doi


Antineoplastic Combined Chemotherapy Protocols--pharmacology
Cell Line, Tumor
Cell Proliferation--drug effects
Everolimus
Humans
Imidazoles--administration & dosage
Neuroendocrine Tumors--drug therapy
Pancreatic Neoplasms--metabolism
Phosphorylation
Quinolines--administration & dosage
Signal Transduction
Sirolimus--administration & dosage
TOR Serine-Threonine Kinases--antagonists & inhibitors